Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Medidata
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Medidata
-
Prikvačeni tweet
We're thrilled to come back to
#SCOPE2020! Hear from our@jackiekent as she shares her excitement and make sure to come meet our team at booth #805! http://bit.ly/39MhnNL#ClinicalTrials#Lifesciences#Clinicalresearchpic.twitter.com/sYXYHSVBHhHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Podcast: tune in as our Mark Glover, shares his journey in the#lifesciences industry w/@JHDinfo. How it all started + the passion that keeps him focused on#patient outcomes driven through#digitalengagement and#transformation w/#healthcare pros: http://bit.ly/34zleu2 pic.twitter.com/ipzk9RAIWb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#News: In a survey with@Newsweek we discovered that 84% of senior#lifescience executives agree that#precisionmedicine represents a new era in drug development, highlighting the need for data-centric#AI tools & a connected ecosystem. More info here: http://bit.ly/3071Hnh pic.twitter.com/vUgwfn3GaY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Blog:@InformaEngage, on behalf of Medidata, conducted a#survey finding that 90% of ClinOps personnel say their workload related to#clinicaltrial oversight has increased. Find out why in the first of a four-part series: http://bit.ly/2NVGTa9#unifiedplatform#lifesciencespic.twitter.com/gzaGDMxGdW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#SCOPE2020: Join our@PatientEngager, Matt Noble, as he kicks off a session on implementation case studies such as digital#biomarkers in#clinicaltrials & a wearable sensor platform in a#heartfailure trial.@SCOPEsummit http://bit.ly/2Ov4ZJg#clinicalresearchpic.twitter.com/GyRr665mdW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#VIDEO: “We believe that we need to continue to strive to do better,” says Lyndsay Harris, Head of Global CSR and ESG reporting at Medidata, in our latest podcast. Watch here: http://bit.ly/2S45ESM#LifeSciences#CSRpic.twitter.com/Zor6RKXWT3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#News: Check out@c_hebenstreit’s interview with@JamieBell97 via@NSBusinessHub ahead of#WorldCancerDay
on how new technologies used in #clinicaltrials could accelerate the number of new#cancer drugs. http://bit.ly/398u84m#CancerResearch#CancerAwareness#CancerDay2020Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#News: Watch as our@Bryantific talks about his presentation from#ASH2019 w/@gohealio re the use of synthetic control arms in#clinicaltrials + the success his team had in replicating a control group using a synthetic approach in multiple myeloma study: http://bit.ly/2Q2Ch23 pic.twitter.com/cFhglmZh92
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#News: We're thrilled to see our strategic business development, Sheila Diamond, celebrated by@io360 as one of their women leadership in immuno-oncology group. Congrats, Sheila
http://bit.ly/2OsmObN
#womenwholead#womenleadership#leadership#lifesciences#ImmunoOncologypic.twitter.com/LvzEPXtLDJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#SCOPE2020: Are site-less, de-centralized or virtual trials the same model? In this session, our@findajc SVP,#mHealth, joins an expert panel to discuss#virtualtrials, the technology behind it & specific challenges in retaining patients + investigators: http://bit.ly/2RRXG0e pic.twitter.com/Sdm4bDT6QG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On-Demand
#Webinar: How do we efficiently & effectively leverage vast datasets to gain insights & visibility into patient treatments & outcomes? Watch to see how a connected#data platform unifies disparate data sources: http://bit.ly/309fPcj#ClinicalTrials#patientsfirstpic.twitter.com/NsQHWbHY5u
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Download this
#eBook to learn about our#unifiedplatform, Medidata Rave Clinical Cloud & how it drives#innovation by tackling#clinicaltrial management challenges and improves overall operational efficiencies. http://bit.ly/2Rb5fh3#productivity#lifesciences#drugdiscoverypic.twitter.com/5OBiv6yDhm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Webinar: Having a strategic roadmap to navigate & meet the requirements for#FDAapproval is a crucial step in the process. In this session, Sharon Ayd shares her expert knowledge of how to navigate + submit correct forms and meet#FDA requirements: http://bit.ly/2tAQ1dn pic.twitter.com/BnwEb6A0aQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Medidatians: Meet Marc. His team has many responsibilities, one of which is to evaluate + update stakeholders on the state of quality for the products/services we release. See how our mission has impacted him… maybe he is#Batman after all
http://bit.ly/2OpdXrf pic.twitter.com/JGNRvZpoJ5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#SCOPE2020: Join our real-world data expert Marc Berger as he kicks off a session focused on how using real-world evidence can improve#clinicalstudy design as well as using#RWE in regulatory settings.@SCOPESummit http://bit.ly/2UjOcwd#Clinicalresearch#clinicaltrials#RWEpic.twitter.com/E3PHs3h7a1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#VIDEO: "It's our responsibility as a company to really have an impact," says Lyndsay Harris, Head of Global CSR and ESG reporting at Medidata, in our latest podcast. Watch here: http://bit.ly/38ZxqH8#LifeSciences#CSRpic.twitter.com/Hoh839F0WU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#News: Following an investment pledge by the British Prime Minister into NHS AI lab, our gm & svp, EMEA,@c_hebenstreit shared his thoughts on the subject matter incl. challenges & future developments in#AI w/@MedicalTechMag http://bit.ly/35R4XBr#clinicalTrialspic.twitter.com/LWTnHf7C4n
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#NEWS: In this issue of@PharmaVOICE, our@findajc shares his perspective on how#virtualtrials play a pivotal role in the future of digital#healthcare for the#lifesciences industry. See what other technologies are making an impact & driving change: http://bit.ly/34JJeeO pic.twitter.com/WeY4M3L0ik
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#SCOPE2020: It's essential for patients to have a clear understanding of all aspects during a#clinicaltrial. In this session,@stales, a 3x#cancersurvivor + trial volunteer will draw from#experience & share her perspective@SCOPEsummit: http://bit.ly/39MhnN#patientsfirstpic.twitter.com/lXQxzA06JG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sponsors and CROs face challenges when it comes to managing, reporting + executing
#sitepayments. As the only end-to-end global site payment solution, Rave Site Payments integrates with any#EDC to trigger payments quickly and accurately. Learn more here: http://bit.ly/2NXk7zu pic.twitter.com/AD1KWRKTLy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#News: In a survey with@Newsweek we discovered that 84% of senior#lifescience executives agree that#precisionmedicine represents a new era in drug development, highlighting the need for data-centric#AI tools & a connected ecosystem. More info here: http://bit.ly/3071Hnh pic.twitter.com/kGUPl2GkGM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.